Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...

In the PANORAMA-HF trial, children receiving sacubitril/valsartan for their heart failure experienced clinically meaningful improvements similar to those seen in children receiving enalapril, although ...

When the patient arrived, she was breathing faster than normal and had been progressively tired and sweaty when feeding. Her temperature was 97.7 °F, with pulse of 175, respiration 70, blood pressure ...

A genetic variant is likely putting some children suffering with myocarditis — inflammation of the heart muscle — at higher risk of developing heart failure, which can be fatal, according to a study ...

The US Food and Drug Administration (FDA) has approved sacubitril/valsartan (Entresto, Novartis) for the treatment of symptomatic heart failure (HF) with systemic left ventricular systolic dysfunction ...

Although you may not think of children when you imagine someone with heart problems, congenital heart defects are actually the most common birth defect in the U.S., occurring in about 1% of births.

Severe pediatric cardiac decompensation has a mortality risk of 50-65% and is the leading cause of death in children. Heart transplantation is the current standard of care for end-stage pediatric ...

Renowned visionary English physician William Harvey wrote in 1651 about how our blood contains all the secrets of life. “And so I conclude that blood lives and is nourished of itself and in no way ...

A University of Houston pharmacology researcher and expert in cardiac development has identified a new cause of—and repair for—left ventricular non-compaction, also known as spongy heart disease. The ...

The ACC issued new guidance for managing common pediatric left-to-right shunts, including ASD, VSD, and PDA, in the ...